Time-Dependent Changes in the Luminal Surface and Mass of the Rat Colon during Prolonged Systemic Treatment with Epidermal Growth Factor

References

• References
   Google Scholar
• Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995;19:183–232.
   PubMed Web of Science ®Google Scholar
• Vinter-Jensen L. Pharmacological effects of epidermal growth factor (EGF) with focus on the urinary and gastrointestinal tracts. APMIS 1999;107 Suppl 93:5–43.
   PubMedGoogle Scholar
• Juhl CO, Vinter-Jensen L, Poulsen SS, Ørntoft TF, Dajani EZ. Chronic treatment with epidermal growth factor causes esophageal epithelial hyperplasia in pigs and rats. Dig Dis Sci 1995;40:2717–23.
   PubMedGoogle Scholar
• Vinter-Jensen L, Smerup M, Kissmeyer-Nielsen P, Poulsen SS. Chronic systemic treatment with epidermal growth factor in the rat increases the mucosal surface of the small intestine. Regul Pept 1995;60:117–24.
   Google Scholar
• Kissmeyer-Nielsen P, Vinter-Jensen L, Smerup M. Effects of longterm epidermal growth factor treatment on the normal rat colon. Gut 1996;38:582–6.
   PubMed Web of Science ®Google Scholar
• Juhl CO, Vinter-Jensen L, Jensen LS, Nexø E, Djurhuus JC, Dajani EZ. Recombinant human epidermal growth factor accelerates healing of sclerotherapy-induced esophageal ulcers and prevents esophageal stricture formation in pigs. Dig Dis Sci 1994;39:2671–78.
   PubMedGoogle Scholar
• Konturek SJ, Dembinski A, Warzecha Z, Brzozowski T, Gregory H. Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 1988;94:1300–7.
   Google Scholar
• Thompson JS, Saxena SK, Greaton C, Schultz G, Sharp JG. The effect of the route of delivery of urogastrone on intestinal regeneration. Surgery 1989;106:45–51.
   Google Scholar
• Procaccino F, Reinshagen M, Hoffmann P, Zeeh JM, Lakshmanan J, McRoberts JA, et al. Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology 1994;107:12–17.
   PubMed Web of Science ®Google Scholar
• Walker Smith JA, Phillips AD, Walford N, Gregory H, Fitzgerald JD, MacCullagh K, et al. Intravenous epidermal growth factor/urogastrone increases small-intestinal cell proliferation in congenital microvillous atrophy. Lancet 1985;2:1239–40.
   PubMedGoogle Scholar
• Sullivan PB, Brueton MJ, Tabara ZB, Goodlad RA, Lee CY, Wright NA. Epidermal growth factor in necrotising enteritis. Lancet 1991;338:53–54.
   PubMed Web of Science ®Google Scholar
• Luck MS, Bass P. Effect of epidermal growth factor on experimental colitis in the rat. J Pharmacol Exp Ther 1993; 264:984–90.
   PubMed Web of Science ®Google Scholar
• Foster HM, Whitehead RH. Intravenous but not intracolonic epidermal growth factor maintains colonocyte proliferation in defunctioned rat colorectum. Gastroenterology 1990;99:1710–4.
   PubMed Web of Science ®Google Scholar
• Goodlad RA, Playford RJ. Epidermal growth factor and intestinal growth. Gastroenterology 1995;108:1330–1.
   PubMedGoogle Scholar
• Lindstram C, Rosengren J-E, Fork F. Colon of the rat. Acta Radiol 1979;20:523–36.
   Google Scholar
• Kissmeyer-Nielsen P, Christensen H, Laurberg S. Diverting colostomy induces mucosal and muscular atrophy in rat distal colon. Gut 1994;35:1275–81.
   Google Scholar
• Baddeley AJ, Gundersen HJG, Cruz-Orive LM. Estimation of surface area from vertical sections. J Microsc 1986;142:259–76.
   Google Scholar
• Ladekarl M. The influence of tissue processing on quantitative histopathology in breast cancer. J Microsc 1994;174:93–100.
   PubMed Web of Science ®Google Scholar
• Vinter-Jensen L, Flyvbjerg A, Nex0 E. Systemic treatment with epidermal growth factor causes organ growth concomitant with reduced circulating levels of IGF-I and IGFBP-3: time-dependent changes in female rats. Growth Horm IGF Res 1998;8: 411–9.
   Google Scholar
• Breider MA, Bleavins MR, Reindel JF, Gough AW, de la Iglesia FA. Cellular hyperplasia in rats following continuous intravenous infusion of recombinant human epidermal growth factor. Vet Pathol 1996;33:184–94.
   Google Scholar
• Marachin R, Bussi R, Gonz A, Orlando L, Pirovano R, Nyska A. Toxicological evaluation of u-hEGF. Toxicol Pathol 1995;23:356–66.
   PubMedGoogle Scholar
• Vinter-Jensen L, Nielsen K. The effects of exogenous epidermal growth factor on the developing urinary tract in rats: a stereological description. Urol Res 1998;26:105–10.
   Google Scholar
• Thompson JF, Van Den Berg M, Stokkers PCF. Developmental regulation of epidermal growth factor receptor kinase in rat intestine. Gastroenterology 1994;107:1278–87.
   PubMed Web of Science ®Google Scholar
• Carpenter G, Cohen S. Human epidermal growth factor and the proliferation of human fibroblasts. J Cell Physiol 1976;88:227–37.
   PubMed Web of Science ®Google Scholar
• Hollenberg MD. The acute actions of growth factors in smooth muscle systems. Life Sci 1994;54:223–35.
   PubMed Web of Science ®Google Scholar
• Takayanagi I. Effects of urogastrone on mechanical activities of the stomach and intestine of guinea-pig. J Pharm Pharmacol 1980;32:228–30.
   PubMed Web of Science ®Google Scholar
• Noguchi S, Yura Y, Sherwood ER, Kakinuma H, Kashihara N, Oyasu R. Stimulation of stromal cell growth by normal rat urothelial cell-derived epidermal growth factor. Lab Invest 1990;62:538–44.
   PubMedGoogle Scholar
• Gabella G. Hypertrophy of intestinal smooth muscle. Cell Tissue Res 1979;201:277–88.
   PubMed Web of Science ®Google Scholar
• Park H, Goodlad RA, Ahnen DJ, Winnett A, Sasieni P, Lee CY, et al. Effects of epidermal growth factor and demethylhydrazine on crypt size, cell proliferation and crypt fission in the rat colon. Am J Pathol 1997;151:843–52.
   PubMedGoogle Scholar
• Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3–34.
   PubMed Web of Science ®Google Scholar
• Winesett DE, Ulshen MH, Hoyt EC, Mohapatra NK, Fuller CR, Lund PK. Regulation and localization of the insulin-like growth factor system in small bowel during altered nutrient status. Am J Physiol 1995;268:G631–40.
   Google Scholar
• Drumm B, Cutz E, Tomkins KB, Cook D, Hamilton JR, Sherman P. Urogastrone/epidermal growth factor in treatment of congenital microvillous atrophy. Lancet 1988;1:111–2.
   PubMedGoogle Scholar